Compounds > edrophonium

edrophonium and androstane-3,17-diol

edrophonium has been researched along with androstane-3,17-diol in 2 studies

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (100.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Abdulatif, M; Naguib, M2

Trials

1 trial(s) available for edrophonium and androstane-3,17-diol

ArticleYear
Edrophonium priming alters the course of neuromuscular recovery from a pipecuronium neuromuscular blockade.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1991, Volume: 38, Issue:6

    Topics: Adult; Androstane-3,17-diol; Anesthesia Recovery Period; Anesthesia, Inhalation; Anesthesia, Intravenous; Dose-Response Relationship, Drug; Edrophonium; Evoked Potentials; Female; Humans; Male; Muscle Contraction; Neuromuscular Blocking Agents; Neuromuscular Junction; Neuromuscular Nondepolarizing Agents; Pipecuronium; Piperazines; Time Factors; Ulnar Nerve

1991

Other Studies

1 other study(ies) available for edrophonium and androstane-3,17-diol

ArticleYear
Neostigmine and edrophonium for reversal of pipecuronium neuromuscular blockade.
    Canadian journal of anaesthesia = Journal canadien d'anesthesie, 1991, Volume: 38, Issue:2

    Topics: Adult; Androstane-3,17-diol; Edrophonium; Female; Humans; Male; Neostigmine; Neuromuscular Blocking Agents; Neuromuscular Junction; Pipecuronium; Piperazines; Time Factors

1991